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Differentiation of neural crest-derived noradrenergic neurons depends upon signaling mediated downstream of BMP binding to cognate
receptors and involving cAMP. Compiled data from many groups suggest that neurogenesis and cell type-specific noradrenergic marker gene
regulation is coordinated through the expression and function of the basic helix–loop–helix DNA binding protein HAND2 and the homeodomain
DNA binding protein Phox2a. However, information detailing how BMP-mediated signaling and signaling through cAMP are coordinated has
been lacking. We now provide compelling data suggesting that differentiation of noradrenergic sympathetic ganglion neurons depends upon both
canonical and non-canonical pathways of BMP-mediated signaling. The non-canonical pathway involves the activation of protein kinase A (PKA)
independent of cAMP. This is a novel mechanism in neural crest-derived cells and is necessary to support neurogenesis as well as aspects of DBH
promoter regulation involving HAND2 phosphorylation and dimerization. The expression of transcripts encoding HAND2 and Phox2a is
regulated via canonical BMP signaling and thus affects both neurogenesis and cell type-specific gene expression. Interestingly, cAMP- and MapK-
mediated signaling modulate specific target sites in both the canonical and non-canonical BMP pathways. Activity of MapK is required for
HAND2 transcription and thus affects neurogenesis. Signaling affected by cAMP is necessary for the transcription of Phox2a as well as regulation
of DBH promoter transactivation by Phox2a and HAND2. We suggest a comprehensive model that shows how BMP- and cAMP-mediated
intracellular signaling integrate neurogenesis and cell type-specific noradrenergic marker gene expression and function.
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Lineage segregation of neural crest-derived precursors
occurs as a consequence of integrating cell extrinsic instructive
cues with intrinsic networks of intracellular signaling cascades
and transcriptional regulation. Identification of factors influ-
encing the generation of neural crest-derived noradrenergic
sympathetic ganglion neurons has received significant atten-
tion. Neural crest-derived cells that will differentiate as
noradrenergic neurons receive instructive signals from the
neural tube (Teillet and Le Douarin, 1983; Howard and
Bronner-Fraser, 1985, 1986; Stern et al., 1991; Groves et al.,
1995) and from the dorsal aorta where they localize and
ganglionate (Reissmann et al., 1996; Schneider et al., 1999;0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Howard, 2005). Although the relevant neural tube-derived
factor has not been identified (Howard and Gershon, 1993), an
essential role for aorta-derived bone morphogenetic protein
growth factors (BMP) in the differentiation of noradrenergic
neurons is well established (Varley et al., 1995, 1998; Shah et
al., 1996; Reissmann et al., 1996; Schneider et al., 1999;
Howard et al., 2000). BMP4 induces expression of a
transcription factor network that includes the homeodomain
DNA binding proteins Phox2a, Phox2b, and the basic helix–
loop–helix (bHLH) DNA binding protein HAND2 (Howard et
al., 2000). We and others have provided evidence suggesting
that the coordinated expression and function of HAND2 and
Phox2a specify multiple components of a sympathetic norad-
renergic phenotype (reviewed in Goridis and Rohrer, 2002;
Howard, 2005). Both neurogenesis and cell type-specific gene
expression depend upon signaling mediated downstream of
BMP (Reissmann et al., 1996; Lo et al., 1999; Howard et al.,86 (2005) 521 – 536
www.e
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Smad1 to the nucleus (Wu and Howard, 2001). Although
BMP4 induces expression of transcripts encoding Phox2b and
HAND2, it is not known if this is a direct effect on gene
transcription or whether intracellular signaling molecules
recruited to non-canonical BMP-mediated signaling pathways
are required intermediates.
A role for signaling downstream of cyclic AMP (cAMP) in
the generation of noradrenergic neurons has been established
(Maxwell and Forbes, 1990; Dupin et al., 1993; Shah et al.,
1996; Lo et al., 1999) although the proximal signal activating
cAMP and the downstream effects of its stimulation remain
unclear. Initially, it was shown that chick embryo extract (CEE)
induces differentiation of noradrenergic neurons (Howard and
Bronner-Fraser, 1985, 1986) as well as stimulating adenylate
cyclase activity (Dupin et al., 1993). These studies suggested
that extrinsic signals induced the differentiation of noradren-
ergic neurons in vitro and the involvement of cAMP was
inferred by demonstrating that direct activation of adenylate
cyclase with forskolin induced expression of TH (Dupin et al.,
1993). A more complicated picture emerged as it became clear
that the response to cAMP is dose-dependent with low levels of
cAMP supporting biosynthesis of norepinephrine while higher
concentrations are inhibitory (Maxwell and Forbes, 1990;
Bilodeau et al., 2000). These data suggested that cAMP might
act as a switch in neuronal precursor cells to regulate their
differentiation into noradrenergic neurons by affecting expres-
sion of transcripts encoding Phox2a and MASH1 (Maxwell
and Forbes, 1990; Bilodeau et al., 2000). Although these early
studies suggested that cAMP-mediated signaling had an impact
on specification of neurotransmitter phenotype, questions
relating to neurogenesis and the function of BMP remained
exigent.
For differentiation of sympathetic noradrenergic ganglion
neurons, both BMP and cAMP have demonstrated significant
roles. The expression and function of Phox2a may be the focal
point linking BMP- and cAMP-mediated signaling to norad-
renergic cell type-specific gene expression. The specification of
neurotransmitter identity depends in part upon cAMP (Lo et al.,
1999). In rodent neural crest-derived stem cells, expression of
the catecholaminergic marker gene, tyrosine hydroxylase (TH),
is dependent upon both cAMP and Phox2a. Interestingly,
expression of the noradrenergic marker gene, dopamine-h-
hydroxylase (DBH) and pan-neuronal genes, requires both
BMP and cAMP (Lo et al., 1999). These data suggest that
Phox2a, alone, is sufficient to induce expression of catechol-
aminergic cell type-specific marker genes (Lo et al., 1998;
Howard et al., 2000) but is not sufficient to support expression
of noradrenergic or pan-neuronal genes (Lo et al., 1998).
Although this study provided evidence for a cAMP-dependent
function of Phox2a in specifying neurotransmitter identity, it
left open the question of linkage between the function of BMP
and cAMP in neuronal differentiation. This link may be based
in the function(s) of HAND2.
These data suggest that the integrated expression and
function of TH and DBH necessary for norepinephrine
biosynthesis require the coordinated expression of severalenvironmentally-derived signals as well as transcriptional
regulators in addition to Phox2a. HAND2 has been identified
as an essential determinant of the noradrenergic phenotype
(Howard et al., 1999, 2000) as well as a co-transcriptional
regulator of DBH expression (Xu et al., 2003; Rychlik et al.,
2003). In total, these data suggest multiple effects of cAMP in
neurogenesis and expression and function of DBH. Because of
the central role of Phox2 proteins and HAND2 in both
neurogenesis and noradrenergic cell type-specific gene expres-
sion (reviewed in Goridis and Rohrer, 2002; Rohrer, 2003;
Howard, 2005), we undertook to determine at what points along
the path of differentiation as noradrenergic neurons neural crest-
derived cells require BMP and/or cAMP-dependent signaling
for differentiation and/or synthesis of norepinephrine. Our
results suggest that BMP4-mediated intracellular signaling
involves both canonical and non-canonical pathways. We
present evidence that neurogenesis and noradrenergic marker
gene expression is integrated, downstream of BMP4, by cAMP.
We provide a comprehensive model suggesting that BMP4 is an
instructive signal to neural crest-derived cells via its canonical
signaling pathway. This aspect of signaling supports transcrip-
tion of HAND2 that is required for neuogenesis and differen-
tiation as noradrenergic neurons. Additionally, BMP4 provides
a permissive signal, via a non-canonical pathway, supporting
neurogenesis and DBH function; components of each of these
pathways are influenced by cAMP.
Materials and methods
Neural crest cell culture
Neural crest cells were obtained from stage 13–14 (Zacchei, 1961) quail
embryos (Coturnix coturnix japonica) as previously described (Howard and
Bronner-Fraser, 1985, 1986; Howard et al., 1995, 1999; Wu and Howard,
2001). Briefly, fertile quail eggs (Bear Bayou Quail Farm, Channelview, TX)
were incubated at 38-C for 43–47 h. Using electrolytically sharpened tungsten
needles, a fragment containing the last eight developed somites and associated
neural tube, was surgically removed from embryos. The tissue blocks were then
incubated in 0.5% collagenase A (Roche, Indianapolis, IN) for 12 min at room
temperature, and gentle trituration used to release the neural tube. The neural
tubes were washed and collected in fresh growth medium (as described below)
and plated on 35-mm tissue culture plates coated with 24 Ag/ml fibronectin (BD
Bioscience, Bedford, MA). After 14–16 h in culture, the neural tube explants
were removed from the dish, leaving behind the neural crest cells that had
migrated from the explant onto the dish. To document complete removal of
neural tube cells, plates were visually screened for the presence of motoneurons
on culture day two; no dishes containing motoneurons were used in the studies
reported in this paper. At the time the explants were removed, growth medium
was changed and every other day thereafter, for the entire culture period.
Growth media and reagents
Neural crest cell cultures were fed with Eagle’s minimal essential medium
(Invitrogen Corp., Carlsbad, CA) supplemented with 15% v/v horse serum
(Omega Scientific Inc., Tarzana, CA) and either 2% or 10% 11-day chicken
embryo extract (CEE, 2% or 10%, v/v) prepared as previously described
(Howard and Bronner-Fraser, 1985). In some experiments, BMP4 and/or
pharmacological inhibitors or analogs of cAMP or PKA were added to growth
medium. BMP4 (R&D Systems, Minneapolis, MN) was added to a final
concentration of 10 ng/ml at the time of plating, and with each change of
growth media, unless otherwise stated. To inhibit the activity of adenylate
cyclase, 2V,5V-dideoxyadenosine (dda) (Calbiochem, La Jolla, CA) or SQ
22,536 (Sigma, St. Louis, MO) was added to growth medium in DMSO at a
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AM) (Calbiochem, La Jolla, CA) or KT 5720 (1 AM) (Sigma, St. Louis, MO)
was added to neural crest cells at the time of plating and every second day
thereafter, unless otherwise stated. Inhibitors of cAMP and PKA were
reconstituted in DMSO (0.1%–0.4% final concentration); in vehicle control
experiments, DMSO was found to have no effect upon cell growth, viability, or
noradrenergic differentiation (Howard, unpublished data). The cAMP analog,
8-bromoadenosine 3V,5V-cyclic monophosphate (8-Br-cAMP, Sigma, St. Louis,
MO), was used at a final concentration of 1 AM.
Catecholamine histofluorescence
Cells synthesizing and storing norepinephrine were detected by the
formaldehyde induced fluorescence (FIF) method of Falck and Torp (1962)
as previously described (Howard and Bronner-Fraser, 1985; Howard and
Gershon, 1993; Howard et al., 1999). Briefly, the growth medium is aspirated
from culture plates and the cells are heat fixed under a stream of hot air. The
cells are exposed to formaldehyde vapor at 80-C for 1 h, cover-slipped in
mineral oil, and visualized using a catecholamine filter set. To assess the
differentiation and phenotypic expression of the noradrenergic marker, NE, the
number of cells showing NE histofluorescence (FIF) was counted in a
minimum of 10 randomly chosen microscope fields from each explant on a
culture plate. For each growth condition or treatment, a minimum of nine
explants from three separate platings were counted, unless otherwise stated.
Assay of protein kinase A activity
The activity of protein kinase A (PKA) was determined in neural crest cells
derived from 15–20 explants grown in 2% or 10% CEE-medium with or
without added BMP4 (10 ng/ml) and added dda (200 AM) or H-89 (10 AM). To
determine the effect of added 8-Br-cAMP on levels of PKA activity, neural
crest-derived cells were grown in 2% CEE or 10% CEE-medium in the
presence or absence of added 8-Br-cAMP (1 AM). For those studies where the
effect of pharmacological intervention was being tested, neural crest-derived
cells were maintained in culture for a period of 7 days. Cells were harvested by
scraping and homogenizing on ice in extraction buffer (modified Radio-
immunoprecipitation buffer (RIPA)) containing 50 mM Tris–HCl (pH 7.4),
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 10 mM h-
mercaptoethanol, 1 mM phenylmethysulfonyl fluoride, and 10 Ag/ml of each
of the following protease inhibitors: leupeptin, aprotinin, and sodium vanadate.
The activity of PKA was determined using the SignaTECT\cAMP-Dependent
Protein Kinase (PKA) Assay System, according to manufacturer’s directions
(Promega, Madison, WI).
Accumulation of cAMP
The ability to mobilize cAMP in neural crest-derived cells was determined
using an 125I-cAMP RIA kit according to manufacturer’s directions (Amersham
Bioscience, Piscataway, NJ). For each determination, neural crest-derived cells,
from 15–20 neural tube explants, were pooled and cAMP extracted after 7 days
in culture. cAMP was extracted by treating the cultures with 300 Al ice-cold
70% ethanol for 12–16 h at 20-C. For each dish, extracted material was
transferred to a 1.5 ml centrifuge tube and spun at 14,000  g (13,000 rpm) for
10 min at 4-C. The supernatant was recovered in a fresh tube. Pellets were
washed with 100 Al of 70% ethanol and centrifuged again at 14,000  g
(13,000 rpm) for 10 min at 4-C, and the second supernatant was combined with
the first. Protein was determined in the pellet using the Bio-Rad DC protein
assay kit according to manufacturer’s instructions (Bio-Rad, Hercules, CA).
Supernatants were dried by vacuum evaporation for 2.5–3 h, and the dried
material was reconstituted in 200 Al of the RIA buffer. The amount of cAMP in
each sample was determined according to the manufacturer’s instructions and
based on a standard curve with known amounts of cAMP ranging from 25
fmol/tube to 1600 fmol/tube. Each sample was measured in duplicate.
Semi-quantitative RT-PCR
Total cellular RNA was purified from the outgrowth of 15 to 20 primary
neural crest explants (per point) using the RNeasy Mini kit (QIAGEN Inc.,Valencia CA) according to manufacturer’s directions. Following RNase-free
DNase I (QIAGEN Inc., Valencia CA) treatment, 1 Ag purified cellular RNA
was used as template for first strand synthesis using 1 unit of SuperScript
reverse transcriptase (Invitrogen Corp., Carlsbad, CA), 0.5 mM each dNTP,
3 mM MgCl2, 10 mM DTT, 2 units RNaseOUT ribonuclease inhibitor
(Invitrogen Corp., Carlsbad, CA), and 5 AM random hexanucleotides in a
final volume of 20 Al. First-strand synthesis was carried out for 50 min at
42-C. The DNA–RNA hybrids were denatured at 75-C for 15 min and then
cooled on ice for 5 min prior to PCR amplification. Equivalent aliquots of
first strand cDNA were amplified using primers specific for HAND2,
Phox2a, or chicken h-actin. The final reaction contained 0.2 mM dNTPs,
0.4 AM of each primer, 1.5 mM MgCl2, and 1 unit Platinum Taq
polymerase (Invitrogen Corp., Carlsbad, CA). For the amplification of
HAND2, the cycler protocol was 94-C, 4 min, then 27 cycles of: step 1,
94-C, 75 s, step 2, 55-C, 75 s, step 3, 72-C, 75 s, and a final elongation
step, 72-C, 10 min. For the amplification of Phox2a, the cycler protocol was
94-C, 4 min, followed by 31 cycles of 94-C, 60 s, 55-C 60 s, 72-C, 60 s,
and 72-C 10 min. Upon completion of the PCR reaction, amplicons were
maintained at 4-C until fractionation in a 1.5% agarose gel. In pilot studies,
we established that amplification of HAND2, Phox2a, or h-actin transcript
was not saturated and that our assay was done in the linear range of
amplification.
Quantitative real-time PCR
Changes in levels of transcript encoding HAND2 and h-Actin (as
internal control) following treatment with BMP4 and/or dda and H-89 were
established using RT-based real-time PCR as previously described (Zhou et
al., 2004). cDNA samples equivalent to 50 ng of total RNA were
incubated with forward and reverse primers (0.4 AM), Taqman probe (0.1
AM), and Taqman universal PCR master mix (Roche, Branchburg, NJ). The
Taqman probes were labeled at the 5V end with 6-FAM (carboxyfluorescein,
reporter dye) and TAMRA (tetramethylrhodamine, quencher dye) at the 3V
ends. Selection of HAND2 and h-Actin gene-specific primers and probes
was optimized using Applied Biosystems (Foster City, CA) Primer-Express
software. Initially, a validation experiment was performed to demonstrate
that the efficiencies of target (HAND2) and reference (h-actin) were
approximately equal. For this purpose, a dilution series of 5 ng, 10 ng, 20
ng, 50 ng, and 100 ng of total RNA was used to define the appropriate
input cDNA. The real-time RT-PCR reaction was performed essentially
following the manufacturer’s protocol. Briefly, reaction mixture was
prepared fresh for each real-time PCR run and contained 5.5 mM MgCl2,
200 AM dNTP, 400 AM dUTP, 1 U UDG, 200 nM FAM-probe, and 400
nM of both forward and reverse primers, 1.5 unit of AmpliTaq Gold DNA
polymerase in a final volume of 25 Al, and was analyzed in an ABI
PRISM 5700 Sequence Detection System. Thermal cycling conditions were
designed as follows: initial denaturation at 95-C for 10 min followed by
40 cycles of 95-C for 15 s and 60-C for 45 s. All amplification reactions
were performed in triplicate. The increase in generation of PCR product is
monitored directly and is based on the threshold number of cycles (CT)
required to produce a detectable change in fluorescence. Values of the
threshold cycle, CT, were averaged from the values obtained from each
reaction.
Relative levels of HAND2 cDNA (RHAND2) in control and test samples
(BMP4, H-89, and dda-treated cultures) were calculated from the difference
in CT values (DCT=DCTcontrolDCTtest) for HAND2 amplifications
(DCTHAND2) compared with those for the housekeeping gene, h-actin








In separate studies, the real-time PCR amplification efficiencies (E)
were determined from the slope of CT vs. input log cDNA dilution where
E =101/slope. E values for amplifying HAND2 and h-Actin cDNAs were 2.01
and 2.28, respectively. It should be noted that we were unable to identify a
functional probe and primer set for Phox2a. In independent studies, we have
determined that we obtain similar results using our standard semi-quantitative
PCR protocol and real-time PCR.
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To identify proliferating cells, incorporation of the thymidine analog BrdU
was performed on culture day 2. Neural crest-derived cells were incubated for
4 h in growth medium containing 50 AM 2V-bromodeoxyuridine, washed in
PBS, and fixed in 4% formaldehyde, freshly prepared from paraformaldehyde,
for 1 h. For immunostaining of BrdU-labeled samples, cells were permeabilized
in PBS containing 0.3% Triton X-100 and DNAwas denatured using 2 N HCl
at room temperature for 30 min. Acid was neutralized by incubation in 1 M
borate buffer, pH 8.4, at room temperature for 30 min. Prior to incubation in
primary antibody, non-specific binding was blocked by incubation in PBS
containing 10% horse serum and 0.3% Triton X-100 for 30 min to 1 h at room
temperature. Cells were incubated in anti-BrdU antibody (1:10, Developmental
Studies Hybridoma Bank) in PBS containing 4% horse serum and 0.3% Triton
X-100 overnight at 4-C. Following washing (PBS, 3 times 10 min), samples
were incubated with species-specific secondary antibody conjugated to
tetramethylrhodamine (KPL, Inc., Gaithersburg, MD) for 3 h at room
temperature in the dark. Cells were washed in PBS (three times 10 min)
following removal of the secondary antibody and mounted in anti-fade medium
(Vector Laboratories, Burlingame, CA). To label cell nuclei, DAPI (4,6-
diamidino-2-phenylindole) diluted 1:500 in PBS was added to the final wash
for 10 min. Cells were visualized using an Olympus AX-70 fluorescence
microscope.
Transient transfection
Neural crest-derived cells were transfected on culture day 2 using FUGENE
6 reagent (Roche Diagnostics Corp. Indianapolis, IN), according to manufac-
turer’s directions. Optimal conditions for transfection of neural crest-derived
cells were determined testing both plasmid DNA concentration and ratio to
FUGENE 6 reagent. After removal of serum from the growth medium, 0.5 Ag
of pFC-PKA plasmid DNA (Stratagene, La Jolla, CA) and 0.5 Ag of pEGFP-N1
plasmid DNA (Clonetech, Palo Alto, CA) were added per 35 mm culture dish
and maintained from 6–8 h; at this time, serum-free medium was replaced with
complete growth medium. Cell morphology and differentiation of NE neurons
were assessed on culture day 7.
The effect on HAND2-mediated synergistic activation of DBH by mutation
of helix 1 (see below) was tested using HeLa cells in a DBH-luciferase reporter
assay, as we have previously described (Xu et al., 2003). HeLa cells were plated
at a density of 1105 cells per well, in 12 well tissue culture plates. The ratio
of DBH reporter construct (DBH-luc) to pRL-null (Promega Corp. Madison,
WI) was maintained constant at 24:1. HAND2 or Phox2a expression plasmids
were added at 150 ng/well. Total DNA (0.5 Ag) was adjusted using pcDNA1.
At 48 h following transfection, cells were harvested and luciferase reporter
activity measured using a Dual-Luciferase Reporter Assay System (Promega
Corp. Madison, WI). As an internal control for transfection efficiency, all
transfections contained pRL-null encoding Renilla luciferase. All luciferase
assays are reported as values normalized to 1 based on the ratio of Firefly to
Renilla reporter activity in control and experimental transfections.
Mutagenesis
We have previously identified nucleotides encoding amino acids shown to
be phosphorylated in a PKA-dependent manner in helix 1 of HAND2 (Firulli et
al., 2003). Sites phosphorylated in HAND2 helix1 by PKAwere mutated using
the QuickChange Multi Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
CA), according to manufacturer’s directions. Threonine (T) and Serine (S) at
amino acids 112 and 114 of HAND2, respectively, were mutated to Aspartic
acid (HAND2DP) using the primer GGA GCG GCG CAG GGA TCA GGA
TAT CAA CAG CGC CTT CGC. Mutation was confirmed by restriction
digestion and DNA sequencing.
Data analysis
Data are presented as the mean T SEM of normalized values, unless
otherwise indicated. Determination of statistical significance is based on
ANOVA and Bonferroni post hoc test, unless otherwise stated.Results
cAMP/PKA signaling supports noradrenergic phenotypic
expression
To determine if signaling mediated by cAMP could affect
the differentiation of neural crest-derived NE neurons, we
pharmacologically blocked cAMP-mediated signaling then
determined the effect on expression of norepinephrine (NE) as
a marker of noradrenergic differentiation. The cAMP pathway
was blocked proximally using either dideoxyadenosine (dda)
or SQ22536 to inhibit adenylate cyclase or distally using H-
89 or KT5720 to block protein kinase A (PKA) activity.
Neural crest-derived cells were maintained in medium
supplemented with 10% CEE in the presence or absence of
200 AM dda or SQ22536 or 10 AM H-89 or 1 AM KT5720
for 7 days and formaldehyde induced fluorescence (FIF) used
to detect NE. In response to decreasing PKA activity, there
was a significant reduction in the mean number of noradren-
ergic neurons detectable by FIF (Fig. 1A). The differentiation
of noradrenergic neurons was significantly reduced from a
mean of 66 T 3 NE positive cells per field in medium
supplemented with 10% CEE to 17 T 6 or 18 T 6 NE
positive cells per field after addition in 10% CEE-medium
of dda or H-89, respectively (Fig. 1A). This result suggested
that signaling mediated by PKA was involved in the
expression of NE in response to factors present in 10%
CEE. To confirm this result and as a test for specificity of our
pharmacological intervention, the experiment was repeated
using SQ22536 or KT5720 to block adenylate cyclase or
PKA, respectively. In response to blockade of adenylate
cyclase, the number of differentiated noradrenergic neurons
was significantly reduced from a mean of 110 T 6 NE cells
per field to 27 T 5 NE cells per field while inhibition of PKA
resulted in a significant reduction to 33 T 5 NE cells per
field. Overall, blockade of adenylate cyclase reduced the
number of NE cells by approximately 75%, while blocking
activated PKA resulted in the loss of about 72% of NE cells.
These data suggest that factors in 10% CEE-medium induce
expression of cAMP/PKA and that these signaling molecules
influence the differentiation of noradrenergic neurons. Mech-
anistically, this result could reflect a change in the number of
noradrenergic neurons or rather be a manifestation of
alterations in the biosynthesis of NE.
To ask if reduction in the number of noradrenergic
neurons observed in response to altered cAMP-mediated
signaling was due to a change in the generation of additional
neural crest-derived cells, we determined the cell division
index in neural crest cells grown in the presence or absence
of dda or H-89 (Fig. 1B). Neural crest explants were plated
in 10% CEE-medium in the absence or presence of 200 AM
dda or 10 AM H-89 and maintained for 2 days. Incorporation
of BrdU was used to determine if pharmacological treat-
ments used to affect a change in intracellular signaling by
PKA influenced cell division in neural crest-derived cells.
The proportion of neural crest-derived cells incorporating
BrdU was not detectably affected by treatment with dda
Fig. 1. In 10% CEE-medium, blockade of cAMP signaling in neural crest-
derived cells inhibits synthesis and storage of norepinephrine but has no effect
on cell division. (A) Synthesis and storage of norepinephrine was used as a
marker of noradrenergic differentiation. Neural crest cells were explanted in
10% CEE-medium in the presence or absence of pharmacological blockers of
adenylate cyclase or PKA and the mean number of NE neurons developing
after 7 days in culture was determined based on FIF. Generation of PKA by
cAMP was inhibited proximally by blocking adenylate cyclase with 200 AM
dda or 200 AM SQ22538. Blockade of adenylate cyclase significantly inhibited
generation of cells expressing NE. To confirm signaling downstream of cAMP,
PKA was inhibited using 10 AM H-89 or 1 AM KT5720. Blockade of PKA
resulted in a significant reduction in the mean number of differentiated NE
neurons. For each treatment, NE neurons were counted in the outgrowth from a
minimum of 9 explants from 3 separate platings. The number of cells
expressing NE was counted in 15–20 randomly selected microscope fields of
cells in each neural crest explant. The mean number of neurons counted in each
treatment condition has been normalized to control and is presented as the
percentage of neurons compared to control values (100%). (B) To assess the
potential function of cAMP-mediated signaling on cell proliferation, the
percentage of neural crest-derived cells incorporating BrdU was determined on
culture day 2. Neural crest explants were plated in 10% CEE-medium in the
absence (control) or presence of 200 AM dda or 10 AM H-89 to inhibit
adenylate cyclase or PKA, respectively. The percentage of dividing cells was
determined by counting the total number of cells having incorporated BrdU as a
fraction of total cells labeled by DAPI. The data suggest that signaling mediated
by cAMP/PKA does not influence cell division. For each condition, a minimum
of three neural crest explants were seeded per plate and five randomly chosen
microscope fields per explant were counted. The experiment was repeated three
times. **P < 0.01; ***P < 0.001.
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maintained in 10% CEE (37 T 2%) suggesting that the
reduction in the number of noradrenergic neurons following
inhibition of PKA is not due to altered generation of cells
but rather to altered expression of NE supported by 10%
CEE. One implication of these results is that increasing PKAshould induce further differentiation of NE cells from neural
crest-derived precursor cells.
In order to understand more fully the consequences on
differentiation of noradrenergic neurons by altering PKA,
neural crest-derived cells were treated with the membrane
permeable analogue of cAMP, 8-bromo-cAMP (8-Br-cAMP) to
elevate PKA (Fig. 2). Neural crest explants were plated under
two growth medium conditions: cells were grown in 10% CEE-
medium which is our standard control medium supporting the
differentiation of NE neurons or in 2% CEE-medium which
does not support the differentiation of NE neurons (Howard and
Bronner-Fraser, 1985, 1986; Howard et al., 2000). Initially,
PKA activity under these growth conditions was determined
(Fig. 2A). Basal PKA activity in 10% CEE-medium is signi-
ficantly higher (5 T 1 pmol/min/Ag protein) than in 2% CEE-
medium (2 T 0.2 pmol/min/Ag protein) likely accounting, in
part, for the lack of NE differentiation observed under this
growth condition. The addition of 1 AM 8-Br-cAMP to neural
crest-derived cells grown in either 2% or 10% CEE-medium for
7 days significantly increased PKA activity to 8 T 0.3 pmol/
min/Ag protein or 9 T 0.4 pmol/min/Ag protein, respectively.
The suggestion that PKA activity influences the differentiation
of NE neurons from neural crest-derived precursor cells was
confirmed by demonstrating a substantial increase in the
number of neurons synthesizing NE in response to added 8-
Br-cAMP (Fig. 2B). Neural crest-derived cells were grown in
either 10% CEE-medium or 2% CEE-medium for 7 days in the
presence or absence of 1 AM 8-Br-cAMP and FIF was used to
determine effects on the generation of noradrenergic neurons. In
10% CEE-medium, the number of NE neurons per field
increased from 35 T 3 to 60 T 5 while in 2% CEE-medium
the number increased from 4 T 2 to 15 T 2. Although the
absolute number of noradrenergic neurons is significantly
greater in 10% CEE-medium compared to 2% CEE-medium,
treatment with 8-Br-cAMP in medium supplemented with 2%
CEE resulted in a greater fold enhancement of NE neuron
numbers compared to 10% CEE-medium (Fig. 2B) and a
similar parallel increase in the level of PKA activity (Fig. 2A).
This result raises the possibility that additional factors induced
by PKA and supported by 10% CEE but not 2% CEE, function
as a trigger to promote either the differentiation of NE neurons
or to enhance the generation of neural precursors derived from
neural crest cells. Having demonstrated here that PKA has a
role in the differentiation of NE neurons, we next reasoned that
PKA activity might contribute to the transcriptional control of
HAND2 and/or Phox2a (Fig. 2C). We used semi-quantitative
RT-PCR to detect transcripts encoding HAND2 and Phox2a in
neural crest cultures. Total cellular RNA was purified from the
outgrowth of 20 to 25 neural crest explants maintained for 7
days in the absence or presence of 1 AM 8-Br-cAMP in 2%
CEE-medium or 10% CEE-medium and levels of transcript
encoding HAND2 and Phox2a were determined. Increasing
PKA activity using 8-Br-cAMP resulted in a significant
(P < 0.05) increase in transcript encoding HAND2 and
Phox2a in both 2% CEE-medium (6.9-fold, 8.7-fold, respec-
tively) and 10% CEE-medium (4.9-fold, 2.2-fold, respectively).
These results indicate that PKA has a significant influence on
Fig. 2. PKA activity induced by 8-Br-cAMP supports expression of transcripts encoding HAND2 and Phox2a and promotes differentiation of noradrenergic neurons
independent of cell division. To elevate levels of PKA, neural crest-derived cells were plated in 2% or 10% CEE-medium in the absence (control) or presence of 1 AM
8-Br-cAMP for 7 days and the effect on noradrenergic differentiation determined. (A) Activity of PKA was significantly lower in 2% CEE compared to 10% CEE
suggesting that PKA contributes to the differentiation of NE neurons in 10% CEE-medium. The addition of 8-Br-cAMP to both 2% and 10% CEE-medium (B)
resulted in a significant increase in the mean number of NE cells. In 2% CEE-medium, the increased activity of PKA was sufficient to significantly increase the
differentiation of NE neurons. (C) In 2% CEE-medium, no significant expression of transcripts encoding HAND2 or Phox2a is detectable, accounting for the lack of
NE neurons in this culture condition. Using 8-Br-cAMP to elevate PKA activity supports a significant increase in transcripts encoding HAND2 and Phox2a in both
2% and 10% CEE-medium. Total cellular RNA was purified from the outgrowth of 20–25 primary neural crest explants and used for semi-quantitative RT-PCR.
Data are presented as the ratio of ethidium bromide band intensity for HAND2 or Phox2a to chicken h-actin. Each value represents the mean of 3–4 individual
platings. Statistical significance was determined based on one-way ANOVA and unpaired t test. The differentiation of NE neurons in response to increased levels of
PKA activity (D) occurred independent of increasing cell division. Based on the incorporation of BrdU, cell numbers were not affected by increasing PKA activity in
either 2% or 10% CEE-medium. For PKA assays, each bar represents 3–6 determinations with each sample being assayed in triplicate. For FIF, the mean number of
NE cells was counted in 8–10 randomly chosen microscope fields in each of 6 to 9 primary neural crest explants from three individual platings. The cell division
index was determined (see Materials and methods) by counting cells in 8–10 random microscope fields, per explant (9 explants) from three primary platings.
*P < 0.05; **P < 0.01; ***P < 0.001.
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phenotype. We next tested the possibility that cell number was
being affected by determining the cell division index (Fig. 2D).
Incorporation of BrdU by neural crest cells grown in 10% CEE-
medium (47 T 3%) or 2% CEE-medium (47 T 2%) was not
significantly influenced by the addition of 1 AM 8-Br-cAMP to
either 10% CEE-medium (49 T 2%) or 2% CEE-medium
(50 T 2%) (Fig. 2D). This lack of effect on cell division index
by increasing PKA is consistent with the idea that PKA
promotes the differentiation of NE neurons rather than
increasing the number of neural precursors. Since we and
others (Howard et al., 2000; Wu and Howard, 2001; Lo et al.,
1999; Dupin et al., 1993; Reissmann et al., 1996; Maxwell and
Forbes, 1990; Bilodeau et al., 2000) have shown that both
cAMP/PKA and BMP4 support the differentiation of norad-
renergic neurons from neural crest-derived precursors, we were
interested to know how these signaling pathways might interact.
Additionally, aorta-derived BMP4 appears to be an endogenous
factor responsible for induction of a transcription factornetwork, including HAND2 and Phox2a, required for the
differentiation of NE neurons (Howard et al., 2000).
BMP4 supports noradrenergic differentiation in a
PKA-dependent manner but independent of cAMP
BMP4, both in vitro (Varley et al., 1995; Reissmann et al.,
1996; Varley et al., 1998) and in vivo (Schneider et al., 1999;
Howard et al., 2000), supports the differentiation of neural
crest-derived noradrenergic neurons. In tissue culture, addition
of BMP4 to 2% CEE-medium is sufficient to support the
differentiation of noradrenergic neurons and recapitulates the in
vivo situation (Howard et al., 2000; Wu and Howard, 2001);
although we have shown that Smad1 translocates to the nucleus
following binding of BMP4 in neural crest-derived cells, all of
the signaling pathways involved have not yet been identified.
We therefore asked if signaling downstream of BMP4
intersected with signaling downstream of cAMP. We first
determined the consequences on generation of noradrenergic
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BMP4. Neural crest explants were plated in 2% CEE-medium
supplemented with 10 ng/ml BMP4 in the absence or presence
of dda or H-89 and FIF was performed after 7 days. Under
control conditions in 2% CEE-medium, few if any noradren-
ergic neurons (3 T 1 NE neurons/field) develop but addition of
BMP4 dramatically increases differentiation (167 T 9 NE
neurons/field) of noradrenergic neurons (Fig. 3A). Addition
of dda to block adenylate cyclase had no significant effect on
the ability of BMP4 to support the differentiation of noradren-
ergic neurons (BMP4; 167 T 9 vs. BMP4 + dda; 151 T 9 NE
neurons per field). Addition of H-89 to block PKA activity
significantly reduced the number of noradrenergic neurons
from 167 T 9 neurons/field with added BMP4 to 4 T 2
neurons/field, a number comparable to 2% CEE-medium
alone. To test for specificity of pharmacological blockade,
SQ22536 was used to block adenylate cyclase or KT5720 toFig. 3. BMP4 supports differentiation of noradrenergic neurons in a PKA-
dependent manner. In order to determine if BMP4-mediated differentiation of
neural crest-derived cells into noradrenergic neurons is affected by cAMP/
PKA-mediated signaling, neural crest cells grown in 2% CEE-medium were
treated with 10 ng/ml BMP4 in the presence or absence of (A) 200 AM dda and
10 AM H-89 or (B) 200 AM SQ 22536 and 1 AM KT5720 to block activity of
adenylate cyclase or PKA, respectively. Few if any NE neurons develop in 2%
CEE-medium. Addition of BMP4 significantly supports differentiation of NE
cells in 2% CEE-medium. The ability of BMP4 to support noradrenergic
differentiation of neural crest-derived cells is significantly inhibited by blocking
activity of PKA but remains unaffected by blockade of adenylate cyclase. This
result suggests that BMP4-mediated signaling influences PKA activity
independent of cAMP. Following FIF, NE cells were counted in a minimum
of 9–12 primary neural crest explants from three independent platings. Each
bar represents the mean number of neurons counted in 8–10 randomly selected
microscopic fields per explant. **P < 0.01; ***P < 0.001 compared to
control. DDDP < 0.001 compared to BMP4-treated culture; .P > 0.05
compared to BMP4-treated culture.
Fig. 4. BMP4 promotes neurogenesis independent of generating additiona
cells. (A) To determine if BMP4 promotes noradrenergic differentiation by
generating additional precursor cells, incorporation of BrdU was used to assess
cell division in neural crest-derived cells grown in 2% CEE-medium in the
absence (control) or presence of 10 ng/ml added BMP4. The involvement o
cAMP/PKA-mediated signaling in cell division was determined by blockade o
adenylate cyclase (200 AM dda) or PKA (10 AM H-89) in the presence o
BMP4. The data are presented as the percentage of cells incorporating BrdU as
a function of total cells labeled with DAPI. BMP4 does not influence the
number of cells generated from primary neural crest explants. This resul
suggested that BMP4-mediated signaling influences neurogenesis. In siste
cultures, we tested (B) this conclusion by determining the number of neurons
(cells expressing neuron specific h-tubulin, labeled with TUJ1 antibody
developing in response to BMP4 added in the absence or presence of 200 AM
dda or 10 AM H-89 to block adenylate cyclase or PKA, respectively. The data
are presented as the percentage of total cells (based on DAPI labeling
expressing neuron specific h-tubulin. Treatment of neural crest-derived cells
with BMP4 significantly enhanced the differentiation of NE neurons. This
enhancement was significantly inhibited by blockade of adenylate cyclase and
PKA. This result suggests that PKA activity elevated by BMP4 is involved in
neurogenesis of neural crest-derived cells. Cells were counted in 5–10
randomly selected microscopic fields in each of 9–12 explants derived from
three independent platings. ***P < 0.001 compared to control. DDP < 0.01








)block PKA with comparable results (Fig. 3B). Similar to
treatment with dda, there was no significant reduction in the
number of noradrenergic neurons developing in the presence of
BMP4 + SQ22536 to block cAMP (BMP4; 122 T 13 vs.
BMP4 + SQ22536; 91 T 5 NE neurons per field). However,
addition of KT5720 significantly reduced the ability of BMP4
to support development of noradrenergic neurons (BMP4;
122 T 13 vs. BMP4 + KT5720; 37 T 7). These results raise
the possibility that PKA is activated downstream of BMP4 but
independently of cAMP. Although the mechanism of BMP4-
mediated support of neurogenesis is not known, there are
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type-specific gene regulation at which BMP4 might be active.
One possibility is that BMP4 supports the generation of
additional neuronal precursor cells from neural crest-derived
progenitor cells. To address this possibility, cell number was
determined following incorporation of BrdU at culture day 2 in
2% CEE-medium supplemented with 10 ng/ml BMP4 in the
presence or absence of dda or H-89 (Fig. 4A). There was no
significant effect on cell number by addition of BMP4 or
treatment with either dda or H-89 suggesting that rather than
affecting an increase in neuronal precursor cells, BMP4
promotes neurogenesis; these data also indicate that neither
cAMP nor PKA functions in the generation of noradrenergic
neurons by influencing cell number. We asked if BMP4
influences neurogenesis by counting the number of cells
expressing neuron specific h-tubulin (TUJ1 immunolabeling)
as a function of the total number of neural crest-derived cells
(DAPI labeling). The mean number of neurons (TUJ1+cells)Fig. 5. BMP4 activates PKA independent of cAMP. To demonstrate that BMP4 sti
treated with added BMP4 in the absence or presence of 200 AM dda or 10 AM H-89 a
significantly increased PKA activity in neural crest-derived cells grown in 2% CEE
showed that added BMP4 does not affect a change in basal levels of cAMP present in
short times in response to BMP4, we measured activity of PKA in neural crest-deriv
exposure to 10 ng/ml BMP4. At 5 min treatment with BMP4, PKA activity was si
could activate PKA, we used the BMP4 antagonist NOGGIN (D) to competitively i
activity. Treatment of neural crest-derived cells with Noggin resulted in a dose-depe
2% CEE at 50 ng/ml added NOGGIN. It should be noted that differentiation of NE
results suggest that BMP4-mediated signaling impinges on PKA in a cAMP-indepen
of PKA activity, each assay was done in triplicate from outgrowth of 20–25 p
measurement of cAMP accumulation, each assay was performed in duplicate on c
repeated 4 times. *P < 0.05; **P < 0.01; ***P < 0.001 compared to control. DDwas significantly increased (Fig. 4B) by addition of BMP4
from 4 T 0.7% of total cells to 20 T 1% of total cells.
Although inhibition of cAMP using dda resulted in a small
but significant decrease in neurons to 14 T 1% of total cells,
inhibition of PKA with H-89 significantly reduced neurogen-
esis to baseline levels (5 T 0.9% of total cells). These data
indicate that PKA is a downstream mediator of BMP4-
supported neurogenesis and further suggest that PKA is
activated independent of cAMP.
PKA activity is increased downstream of BMP4 independent of
cAMP-mediated signaling
To directly test the idea that BMP4 activates PKA and does
so without affecting activity of adenylate cyclase, we measured
the accumulation of cAMP and PKA in neural crest-derived
cells grown under conditions supporting different levels of
neurogenesis. Neural crest-derived cells grown in the presencemulates activity of PKA independent of cAMP, neural crest-derived cells were
nd the activity of PKA (A) or accumulation of cAMP (B) was measured. BMP4
-medium independent of cAMP. Measurement of cAMP accumulation directly
2% CEE-medium. (C) To demonstrate that activity of PKAwas enhanced over
ed cells at 1 day in culture in 2% CEE-medium (control) or following a 5 min
gnificantly increased 2-fold. To demonstrate that signaling mediated by BMP4
nhibit BMP4 receptor binding on neural crest-derived cells and measured PKA
ndent loss of PKA activity. PKA activity was reduced to basal levels present in
neurons is inhibited ¨100% by addition of NOGGIN (data not shown). These
dent manner but requiring binding to its cognate receptor. For the measurement
rimary neural crest explants; each experiment was repeated 3–6 times. For
ells derived from 20–25 primary neural crest explants; each experiment was
P < 0.01; DDDP < 0.001 compared to BMP4-treated culture.
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(5 T 0.7 pmol/min/Ag protein) compared to cells grown in 2%
CEE-medium alone (2 T 0.2 pmol/min/Ag protein). No signif-
icant reduction in PKA activity was observed (Fig. 5A) in the
presence of added dda but treatment of cells with H-89 resulted
in a significant reduction of PKA activity resulting in levels
equivalent to baseline (1 T 0.1 pmol/min/Ag protein). Interest-
ingly, the increase in PKA activity measured in response to
added BMP4 was not secondary to increasing the accumulation
of cAMP (Fig. 5B). The amount of accumulated cAMP in
response to factors present in 2% CEE-medium (11 T 0.4 fmol/
Ag protein) was not affected by addition of BMP4 (11 T 1
fmol/Ag protein). Activity of PKA is increased significantly
after 5 min exposure of neural crest cells to BMP4 (Fig. 5C)
suggesting a receptor-mediated event. The increase in PKA
activity occurs secondary to BMP4 binding its receptor since
antagonism of BMP4 using NOGGIN results in a dose-
dependent loss of PKA activity (Fig. 5D) returning to baseline
levels at 50 ng/ml added NOGGIN. In total, these data indicate
that increased activity of PKA occurs downstream of BMP4-
mediated intracellular signaling and independent of cAMP.
These data raise the possibility that genes regulated secondary
to BMP4 and required for differentiation of noradrenergic
neurons are responsive to PKA. In addition, these data suggest
differential effects of PKA depending upon whether PKA
activity is increased secondary to cAMP or BMP4.Fig. 6. Expression of transcripts encoding HAND2 and Phox2a is
differentially regulated downstream of BMP4-mediated signaling. Expression
of transcripts encoding HAND2 (A) and Phox2a (B) was assessed in neural
crest-derived cells treated with BMP4 in the absence and presence of 200
AM dda or 10 AM H-89 to block adenylate cyclase or PKA, respectively.
Real-time RT-PCR (A) and conventional RT-PCR (B) were used to determine
relative levels of transcripts encoding HAND2 and Phox2a, respectively.
Values obtained using real-time RT-PCR were calculated according to the
PCR efficiency and CT value (for detail, see Materials and methods), while
ratios of intensity of ethidium bromide labeled amplicon bands of Phox2a vs.
h-actin were assessed in conventional RT-PCR. All data were normalized to
values obtained from control (neural crest-derived cells grown in 2% CEE-
medium) cells and presented as mean T SEM. We have established that our
semi-quantitative RT-PCR (B) (Howard et al., 2000; Wu and Howard, 2001,
2002) gives similar absolute values for transcript expression compared to
real-time RT-PCR. We were unable to devise a primer pair and probe suitable
for amplification of Phox2a but have established a valid comparison of
values generated by both PCR methods. BMP4 significantly induced
expression of transcripts encoding both HAND2 and Phox2a in neural
crest-derived cells grown in 2% CEE-medium. Inhibition of activated PKA
by addition of H-89 exerted little influence on transcripts encoding HAND2
or Phox2a induced by BMP4. Interestingly, blockade of adenylate cyclase
significantly inhibited expression of transcripts encoding Phox2a with no
significant effect on expression of transcripts encoding HAND2. To confirm
that expression of Phox2a occurs independent of effects on HAND2 by
cAMP, isobutylmethlyxanthine (IBMX, 100 AM) was added in the presence
of BMP4 to increase levels of cAMP (Bilodeau et al., 2000). The level of
transcript encoding Phox2a is significantly increased in the presence of
BMP4 by elevation of cAMP without an effect on expression of transcripts
encoding HAND2. Total cellular RNA was purified from 20–25 primary
neural crest-explants. In each case, PCR samples were run in triplicate from
3–4 separate platings for results presented in panels A and B and from 2
platings for results presented in panel C. *P < 0.05; **P < 0.01;
***P < 0.001 compared to control. DDDP < 0.001 compared to BMP4-
treated cultures. DP < 0.05 compared to BMP4-treated cultures; .P < 0.001
compared to BMP + IBMX (HAND2).Expression of transcripts encoding HAND2 and Phox2a is
differentially influenced by cAMP and PKA in response to
BMP4
We have previously shown that signaling mediated by
BMP4 either directly or indirectly induces expression of
transcripts encoding HAND2 and Phox2a (Howard et al.,
2000; Wu and Howard, 2001; cf. Mizuseki et al., 2003). To
determine if this induction is dependent upon cAMP or PKA,
neural crest-derived cells were grown in 2% CEE-medium in
the absence or presence of 10 ng/ml added BMP4 and either
dda or H-89 and relative levels of transcripts encoding HAND2
and Phox2a were assessed. The induction of transcripts
encoding HAND2 mediated by BMP4 is not dependent upon
generation of either cAMP or PKA (Fig. 6A). Interestingly,
although the expression of transcript encoding Phox2a is not
dependent upon BMP4-induced PKA, it is sensitive to cAMP
(Fig. 6B) suggesting differential regulation in response to
BMP4. To confirm these results, isobutylmethylxanthine
(IBMX, 100 AM) was added to neural crest cell cultures to
Fig. 7. Constitutive expression of PKA transiently transfected in neural crest
derived cells is sufficient to support noradrenergic differentiation. To determine
the effect of constitutive expression of PKA on neuronal differentiation, neura
crest-derived cells were transfected transiently with plasmids expressing PKA
and EGFP. The effect of over-expressing PKA was determined based on
development of morphological characteristics of neurons (A) or the synthesis
and storage of NE (B). On culture day 4, phase bright process bearing cells
observed under Nomarski optics [A1 (control), A3 (+pFC-PKA)] were counted
as expressing PKA and differentiating as neurons based on expression of the
EGFP marker visible under fluorescence optics [A2 (control), A4 (+pFC
PKA)]. Under Nomarski optics, cells with phase bright and round somata were
characterized as neurons (indicated by red arrows in A3 and A4); this was
confirmed under fluorescence optics by making elaborated processes visible. In
control cultures, cells with phase bright cell bodies (A1) were rarely visualized
and cells expressing EGFP (A2) did not elaborate processes (marked with red
arrows in panels A1 and A2). (B) On culture day 7, FIF was used to identify
NE neurons as a measure of neuronal differentiation in response to constitutive
expression of PKA. The enhanced differentiation of neurons evidenced by
acquisition of the morphological characteristics of neurons was confirmed by
the elevated numbers of cells expressing NE in response to expression of PKA
**P < 0.01.
H. Liu et al. / Developmental Biology 286 (2005) 521–536530increase levels of cAMP, in the absence or presence of BMP4
(Bilodeau et al., 2000). In the presence of BMP4, elevation of
cAMP affected a significant increase in transcripts encoding
Phox2a (Fig. 6C) without detectably changing expression of
transcripts encoding HAND2. Thus, as predicted, in the
presence of BMP4, cAMP differentially effected expression
of transcripts encoding HAND2 and Phox2a. These data
suggest that PKA activity induced by BMP4 functions in
aspects of noradrenergic differentiation not involving regula-
tion of HAND2 transcription.
Over-expression of PKA is sufficient to promote differentiation
of noradrenergic neurons
Having demonstrated that BMP4 increases the activity of
PKA as well as supporting differentiation of noradrenergic
neurons, we asked if over-expression of PKA could support
differentiation of noradrenergic neurons from neural crest-
derived cells. We tested this possibility by transiently transfect-
ing neural crest-derived cells on culture day two using a
plasmid constitutively expressing PKA (pFC-PKA) and co-
transfecting with pEGFP-N1 to provide a visible marker of
transfected cells. On culture day four, the morphology of cells
expressing pEGFP was examined under Nomarski optics (Figs.
7A1 [control] and A3 [+pFC-PKA]) or flourescein optics (Figs.
7A2 [control] and A4 [+pFC-PKA]) to determine if cells
expressing EGFP displayed characteristics of neurons such as
process outgrowth and rounded phase-bright cell bodies. On
culture day seven, the number of noradrenergic neurons was
counted following FIF (Fig. 7B); expression of pEGFP falls off
beginning at culture day 4.5–5 obviating directly, demonstrat-
ing that cells transfected with pFC-PKA express noradrenergic
characteristics on culture day 7.
Based on assessment of morphological criteria, we con-
cluded that over-expression of PKA was sufficient to support
the differentiation of neural crest-derived cells into neurons
(compare Figs. 7A2 and A4). Examination of neural crest cells
under Nomarski optics (Fig. 7A3 [+pFC-PKA]) revealed many
cells with phase bright cell bodies characteristic of differenti-
ated neurons (indicated by red arrows in A3 and A4); although
cells with phase bright cell bodies were identified under control
growth conditions (Fig. 7A1), these cells did not elaborate
processes characteristic of neurons (Fig. 7A2). Identification of
cells with phase-bright cell bodies (Fig. 7A3) as neurons was
confirmed under flourescein optics (Fig. 7A4) where cells
expressing PKA also had elaborated processes characteristic of
differentiated neurons; under control conditions, cells trans-
fected with EGFP (indicated by red arrows (A1 and A2)) did
not acquire a neuronal morphology. This morphological
analysis suggested that expression of PKA is sufficient to
support neuronal differentiation of neural crest-derived cell in
vitro. Constitutive expression of PKA also elicited a significant
increase (3.2-fold) in the number of neurons (Fig. 7B)
expressing NE from neural crest-derived cells maintained in
2% CEE-medium.
These data suggest that PKA activity is involved in the
generation of noradrenergic neurons, subsequent to BMP4--
l
-
.mediated intracellular signaling but that this PKA activity does
not influence transcription of HAND2 or Phox2a. We therefore
tested the influence of MapK on expression of transcripts
encoding HAND2 and Phox2a to determine if this arm of the
intracellular signaling pathway (Wu and Howard, 2001) might
influence this aspect of noradrenergic marker gene regulation
(Fig. 8) downstream of BMP4. Neural crest explants were
Fig. 8. MapK is involved in regulation of transcripts encoding HAND2 but not
Phox2a downstream of BMP4. (A) Expression of transcripts encoding HAND2
and Phox2a was determined in cells grown in the absence (2% CEE-medium,
control) or presence of BMP4 and added PD98059 (7 AM) to block MapK-
mediated signaling (Wu and Howard, 2001). Treatment of neural crest-derived
cells with PD98059 for 7 days significantly inhibited the function of BMP4 in
supporting expression of transcripts encoding HAND2 and Phox2a. For RT-
PCR, total cellular RNA was collected from the outgrowth of 20–25 primary
neural crest explants. A representative experiment (from 4) is shown. (B) To
determine if signaling downstream of MapK impinged on BMP4-mediated
signaling, PKA activity was measured in sister cultures from those reported on
in panel A. Blockade of MapK signaling did not significantly impinge on PKA
activity induced by BMP4. Activity of PKA was measured in triplicate in cell
extracts derived from 20–25 primary neural crest explants. The data are
presented as the mean T SEM from 4 separate platings. *P < 0.05;
***P < 0.001 compared to control; DDP < 0.01 compared to BMP4-treated
group.
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ng/ml added BMP4 with or without 7 AM PD98059 to inhibit
MapK (Wu and Howard, 2001; Zhou et al., 2004). While
growth in the presence of BMP4 significantly (P < 0.01)
increased transcripts encoding HAND2 (¨3.1-fold) and
Phox2a (¨2.5-fold; P < 0.05) (Fig. 8A) over that in control
cells grown in 2% CEE-medium alone, inhibition of MapK
blocked effects (P < 0.01) of BMP4 on HAND2 transcript
expression (Fig. 8A); the reduction in expression of tran-
scripts encoding Phox2a by PD98059 was not significant
(P > 0.05). This result raised the possibility that MapK and
PKA function in tandem to regulate different aspects of
noradrenergic differentiation and NE marker gene expression.
To test this possibility, we blocked MapK-mediated signaling
using PD98059 and measured PKA activity in the presence
and absence of added (10 ng/ml) BMP4 (Fig. 8B). When
compared to neural crest-derived cells grown in 2% CEE-
medium (2 T 0.1 pmol ATP/min/Ag protein), addition of
BMP4 significantly increased PKA activity (4 T 0.4 pmolATP/min/Ag protein) but this activity was not reduced in the
presence of PD98059 (3 T 0.3 pmol ATP/min/Ag protein).
Since blockade of MapK does not affect a change in PKA
activity downstream of added BMP4, we suggest that PKA is
regulated independently of MapK by BMP4 and that both
MapK and PKA regulate aspects of BMP4-mediated differ-
entiation of noradrenergic neurons from neural crest-derived
precursors.
PKA-dependent phosphorylation of HAND2 is crucial for
biosynthesis of norepinephrine
Dopamine-h-hydroxylase (DBH) is the biosynthetic en-
zyme required to convert dopamine to norepinephrine; Phox2a
is a homeodomain DNA binding protein that regulates
transcription of DBH (Swanson et al., 1997; Kim et al.,
1998). We have shown previously that HAND2 synergistical-
ly promotes Phox2a-stimulated activity of the DBH promoter
(Xu et al., 2003) implicating HAND2 in cell type-specific
gene expression. We have also demonstrated that functional
dimerization of HAND2 is dependent upon PKA-mediated
phosphorylation of threonine 112 and serine 114 (Firulli et al.,
2003) located in helix1 of HAND2. To determine if this PKA-
mediated post-translational processing of HAND2 has func-
tional consequences for expression of norepinephrine, we
mutated these sites in HAND2 abrogating their phosphoryla-
tion. We then tested the transcriptional activity of the mutant
HAND2 (HAND2DP) protein at the DBH promoter (Fig. 9)
using our standard DBH-luc reporter assay (Xu et al., 2003).
HeLa cells were transiently transfected with HAND2,
HAND2DP, and/or Phox2a, as indicated (Fig. 9) and promoter
activity determined based on a dual luciferase assay (open
bars). Basal promoter activity is only marginally affected by
HAND2 alone but is significantly increased 4.6 T 0.1-fold by
Phox2a. Co-expression of HAND2 and Phox2a significantly
increased DBH-reporter activity 2.6 T 0.1-fold over Phox2a
alone and 12.1 T 0.1-fold over basal promoter activity.
Interestingly, ¨98% of the synergistic activation of DBH
afforded by HAND2 is lost by preventing post-translational
PKA-mediated phosphorylation of HAND2 in helix1. How-
ever, co-expression of Phox2a and HAND2DP marginally
activates DBH transcription over Phox2a alone suggesting
that regulatory elements, in addition to phosphorylation, are
required for the synergistic interaction of HAND2 and Phox2a
at the DBH promoter. We tested the possibility that cAMP
might influence the ability of HAND2 and Phox2a to regulate
DBH (Fig. 9).
Enhancing cAMP expression by growing cells in the
presence of 1 mM 8-Br-cAMP resulted in a significant increase
of Phox2a driven DBH-luc reporter activity (¨2.3-fold,
P < 0.001) compared to Phox2a alone (Kim et al., 1994;
Swanson et al., 1997; Xu et al., 2003). This cAMP-mediated
increase in DBH transcription occurred under all treatment
conditions with Phox2a and HAND2 suggesting that basal as
well as activated transcription is cAMP-modified. As expected,
if the DB1 enhancer CRE is mutated (DBH-CREM), basal
transcription, and in response to Phox2a or HAND2+Phox2a,
Fig. 9. PKA-dependent phosphorylation of HAND2 is critical for synergistic enhancement of Phox2a-dependent transactivation of DBH. HeLa cells grown in the
absence or presence of 1 mM 8-Br-cAMP were transiently transfected with the expression plasmids shown and DBH-luc reporter constructs (Xu et al., 2003). Results
from cells transfected with our wild-type DBH-luc reporter are shown in the clear bars and cells transfected with a DBH reporter construct where the CRE was
mutated using site directed mutagenesis (DBH-CREM) are reported in blue bars. Cells were harvested after 48 h and luciferase activity was measured in cell lysates.
Although Phox2a alone significantly increases basal DBH transcription, HAND2 synergistically enhances Phox2a-dependent DBH-luc reporter activity. Mutation of
threonine 112 and serine 114, creating phosphorylation mutants (HAND2DP), results in a significant loss of HAND2 activity. In the presence of 8-Br-cAMP, DBH
promoter activation by Phox2a and Phox2a plus HAND2 is significantly increased. However, if the CRE is mutated, 8-Br-cAMP loses its potency to enhance
promoter activity in response to Phox2a and HAND2. The data are presented as mean T SEM of normalized luciferase activity from three independent sets of
transfections. The ratio of Firefly to Renilla luciferase activity was normalized to control (pCDNA1) activity. ***P < 0.001 compared to control group;
+++P < 0.001 compared to Phox2a-treated group; DDDP < 0.001 compared to Phox2a+HAND2 group, ###P < 0.001 compared to corresponding groups grown
without 8-Br-cAMP; ***P < 0.001 compared to Phox2a-driven activation of DBH-CREM.
Fig. 10. Schematic representation of BMP-mediated canonical and non
canonical signaling. Signaling downstream of BMPs influences both neurogen
esis and cell type-specific gene expression. HAND2 and Phox2a togethe
coordinate expression of pan-neuronal and cell type-specific genes by linking
BMP-mediated canonical and non-canonical intracellular signaling pathways
Expression of transcripts encoding HAND2 and Phox2a is regulated by
canonical BMP-mediated signaling but is also dependent upon MapK
(HAND2) or cAMP (Phox2a). Neurogenesis and DBH promoter regulation is
dependent upon non-canonical BMP signaling mediated by PKA. The activity
of PKA and cAMP differentially effects target response dependent upon thei
mode of activation. cAMP influences DBH promoter activity while PKA
influences the function of HAND2 (detailed in Fig. 11).
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apparent interaction of HAND2 and Phox2a at the CRE
domain suggested by the small but consistently higher
(P < 0.001) DBH-CREM (***) promoter activity if HAND2
or HAND2DP is present in the transcriptional complex with
Phox2a. The significant decrease in DBH-luc reporter activity
observed with HAND2DP, even in the presence of cAMP,
indicates that PKA-dependent phosphorylation of HAND2 is
crucial for DBH activation.
Discussion
The molecular basis for specification and differentiation of
noradrenergic neurons from neural crest-derived precursors is
being elucidated. In the present study, we have focused on the
consequences to neurogenesis and neurotransmitter biosynthe-
sis of intracellular signaling downstream of BMP4 and cAMP
in neural crest-derived precursor cells, in vitro. The major goal
of these studies was to determine if BMP4-mediated signaling
intersected with signaling through cAMP in order to ascertain
if differentiation as neurons or synthesis of norepinephrine was
specifically targeted by these molecules. Our data suggest that
cAMP functions to coordinate BMP4-mediated signaling via
both canonical (translocation of Smad1/4) and non-canonical
(induction of PKA activity) pathways affecting neurogenesis
(Fig. 10) and regulation of DBH promoter activity (Fig. 11).
Our results account for coordinated expression of pan-neuronal
and cell type-specific genes culminating in the differentiation
of noradrenergic sympathetic neurons.
Impetus for the current studies centered around several
sources of confusion in the literature regarding the requirement
for cAMP to support neurogenesis or expression of neuro-transmitter biosynthetic enzymes (Maxwell and Forbes, 1990;
Lo et al., 1999; Bilodeau et al., 2000) necessary for the
generation of noradrenergic sympathetic ganglion neurons.
Since neuronal identity is determined by expression of both
pan-neuronal characteristics and cell type-specific properties,
identification of extrinsic signals and their function in





Fig. 11. DBH promoter regulation. (A) Under basal condition, Phox2a is phosphorylated and has low binding affinity for its homeodomain (HD) DNA binding sites
(Adachi and Lewis, 2002). Under this condition, DBH transactivation is low. (B) The ability of HAND2 to form functional dimers is dependent upon PKA activity
resulting in phosphorylation of serine 112 and threonine 114 in helix 1 (Firulli et al., 2003). The dephosphorylation of Phox2a is regulated by PKA and most likely
involves the protein phosphatase PP2A and the regulatory subunit B56y (Adachi and Lewis, 2002). The dephosphorylation of Phox2a is required for its binding to
HD sites in the DBH promoter. The presence of HAND2 in the transcription complex enhances the binding affinity of Phox2a for HD binding sites (Rychlik et al.,
2003, in press) and synergistically enhances promoter activity (Xu et al., 2003). HAND2 is dephosphorylated in a PP2A-dependent manner (Firulli et al., 2003) and it
is likely the balance between phosphorylated HAND2 and dephosphorylated Phox2a that contributes to the transcriptional regulation of DBH. (C) Stimulated DBH
transactivation involves CBP/P300 which binds both Phox2a and HAND2 (Swanson et al., 2000; Xu et al., 2003). For synergistic activation of DBH by HAND2, the
CRE/AP1 site is critical (Swanson et al., 1998; Xu et al., 2003); the cAMP-mediated effects on DBH transactivation are regulated through this site (Xu et al., 2003).
The three-dimensional structure and the identity of all components of the transcription unit remain to be elucidated. This model represents our current understanding
of the transcriptional machinery responsible for norepinephrine biosynthesis and serves to underscore the differential requirements for PKA and cAMP.
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circuit (BMPYPhox2bYHAND2YPhox2a) required for the
differentiation of sympathetic noradrenergic neurons, we used
these gene products and the consequences of their expression
as the experimental focal point in which to understand the
interplay between signaling downstream of BMP4 and cAMP.
The most revealing aspect of these studies is that BMP4
induces PKA activity independent of cAMP. Signaling by PKA
downstream of BMP4 affects neurogenesis and the function of
HAND2; identification of this non-canonical intracellular
signaling pathway has made it possible to propose a unifying
model (Fig. 10) that provides a roadmap for generation of
noradrenergic sympathetic ganglion neurons.
cAMP modulates BMP-mediated signaling
Previous studies implicated cAMP as a signaling molecule,
acting either directly or indirectly with BMP, by demonstrating
increased expression of TH in neural crest-derived cells in vitro
in response to added cAMP (Maxwell and Forbes, 1990; Dupinet al., 1993; Lo et al., 1999; Bilodeau et al., 2000). These
studies left open the question of what function cAMP served
and how its function intersected with BMP-mediated
responses. These culture studies suggested that an extrinsic
signal activates cAMP (Lo et al., 1999) but this has not been
confirmed in vitro or in vivo. Levels of cAMP measured in
cells maintained in growth conditions permissive for differen-
tiation of noradrenergic neurons (2% CEE-medium+BMP4)
are equivalent to levels in cells grown in non-permissive
conditions (2% CEE-medium) suggesting that cAMP alone is
not sufficient to support differentiation of noradrenergic
neurons. Neural crest-derived cells maintained in 2% CEE-
medium express CASH1 but little if any Phox2b, HAND2, or
Phox2a (Howard et al., 2000; Howard, unpublished observa-
tion). Lack of expression of the essential determinants of a
noradrenergic phenotype (reviewed in Brunet and Pattyn,
2002) in 2% CEE-medium suggests that cAMP does not
induce expression of these DNA binding proteins. In tissue
culture, BMP4 induces translocation of Smad1/4 to the
nucleus, expression of Phox2, HAND2, and GATA2, and
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of development (Groves et al., 1995; Reissmann et al., 1996;
Schneider et al., 1999; Howard et al., 1999; Wu and Howard,
2001; Howard et al., 2000; Tsarovina et al., 2004). In this
context, the function of cAMP is to modify or modulate the
effects of intracellular signaling pathways induced by BMP.
Our data show that cAMP-mediated signaling impacts both
canonical and non-canonical BMP-mediated signaling path-
ways (Fig. 10). In the canonical pathway, expression of
transcripts encoding Phox2a occurs downstream of HAND2
but requires cAMP. The cAMP-dependent influence on
neurogenesis seen by us and others (Maxwell and Forbes,
1990, Dupin et al., 1993; Lo et al., 1999; Bilodeau et al., 2000)
is thus indirect and involves regulation of Phox2a expression.
The identity of the extrinsic cue inducing cAMP-mediated
PKA activity involved in regulation of Phox2a transcription is
not yet known. In the non-canonical pathway, cAMP impacts
DBH promoter regulation. Together, these data suggest that
HAND2 and Phox2a couple aspects of neurogenesis and cell
type-specific gene expression downstream of BMP but in a
cAMP-dependent manner. Integration of canonical and non-
canonical BMP-mediated signaling requires MapK activity as
well. The expression of transcripts encoding HAND2 is
dependent upon BMP both in vivo (Howard et al., 2000) and
in vitro (Howard et al., 2000; Wu and Howard, 2001; Muller
and Rohrer, 2002) and is modulated by signaling impinging
upon MapK. The influence of MapK- and cAMP-mediated
signaling on expression of transcripts encoding essential
determinants of the noradrenergic phenotype suggests that
canonical BMP-mediated signaling provides an instructive
cue to neural crest-derived precursors for this aspect of
differentiation.
Establishing that BMP4 induces PKA activity, and that the
potential to support differentiation of noradrenergic neurons in
vitro is correlated with the levels of PKA but not cAMP, helps
to explain previous results from studies using cAMP (or other
agents to increase PKA) as a mechanism to affect neuronal
differentiation. For many of these studies, TH was used as a
marker of noradrenergic differentiation (Dupin et al., 1993; Lo
et al., 1998, 1999; Stanke et al., 1999; Bilodeau et al., 2000).
Although mechanisms of TH regulation are not well defined, it
is clear that many extrinsic signals can induce TH (Ghee et al.,
1998; Quinn, 2002; Lewis-Tuffin et al., 2004). Recent data
suggest that CREB is a focal point for transcriptional control of
TH and is independent of the upstream inducing agent (Lonze
and Ginty, 2002; Lewis-Tuffin et al., 2004). This may explain
the previously reported lack of a consistent correlation between
expression of TH, FIF, and transcripts encoding Phox2a
generated by addition of cAMP (Maxwell and Forbes, 1990;
Bilodeau et al., 2000). Our results suggest that PKA generated
independently from cAMP is necessary for HAND2 expression
and the integrated function of Phox2a. This suggests that
signaling via the BMP-mediated non-canonical pathway
provides a permissive signal coordinating neurogenesis and
cell type-specific gene expression and function. The focal point
for integration of BMP-mediated signaling may be the
expression of HAND2 and integrated function of Phox2a.Several lines of evidence indicate that Phox2a is required for
expression of pan-neuronal genes but that it is insufficient alone
to support neurogenesis (Lo et al., 1999; Stanke et al., 1999;
Brunet and Pattyn, 2002). We have previously established the
temporal and epistatic order of expression of Phox2b, HAND2,
and Phox2a in avian embryos (Howard et al., 2000); we suggest
that HAND2 induces expression of Phox2a and that their
epistatic relationship places HAND2 upstream of Phox2a in the
transcription factor network supporting differentiation of
sympathetic noradrenergic neurons (Howard et al., 2000).
Unlike Phox2a, ectopic expression of HAND2 is sufficient to
induce TH, DBH, SCG10, NF, and biosynthesis of norepineph-
rine (Howard et al., 1999, 2000). This suggests that HAND2
and Phox2a together support neurogenesis. In addition,
HAND2 can induce expression of Phox2b which is recognized
as the determinant of autonomic neurons (reviewed in Brunet
and Pattyn, 2002). Both Phox2b and Phox2a can bind to and
transactivate the DBH promoter raising the formal possibility
that it is Phox2b rather than Phox2a interacting with HAND2
that supports differentiation of noradrenergic sympathetic
ganglion neurons. It is at this step, transcription of HAND2,
where BMP-mediated canonical signaling intersects with non-
canonical signaling. This cAMP-independent PKA activity is
required for neurogenesis as well as for phosphorylation of
HAND2 thus linking expression of pan-neuronal and cell type-
specific genes. The function of BMP-mediated signaling does
not impact generation of additional precursors but rather affects
either specification or differentiation as noradrenergic neurons
(and see Stanke et al., 1999).
Synergistic transactivation of DBH promoter by HAND2
requires PKA-dependent phosphorylation in HAND2
dimerization domain
Phox2a and HAND2 together can regulate DBH promoter
activity establishing HAND2 as a transcriptional co-activator
(Xu et al., 2003; Rychlik et al., 2003) and making transmitter
biosynthesis a potential target for regulation by extrinsic
molecules (Fig. 11). Interestingly, although Phox2a can bind
to and transactivate both TH and DBH promoters (Zellmer et
al., 1995; Yang et al., 1998; Kim et al., 1998), differential
effects of cAMP-mediated signals raises the possibility that TH
and DBH are not coordinately regulated; PKA synergistically
enhances Phox2a activity at the DBH promoter but activates
TH independent of Phox2a (Swanson et al., 1997). Thus, in
trying to parse out differential influences of cAMP and/or PKA
on neurotransmitter biosynthesis, we have focused on the DBH
promoter. Our data indicate that DBH expression is regulated
downstream of canonical BMP-mediated signaling but that
promoter function is influenced by both cAMP and BMP-
induced PKA activity in the non-canonical signaling pathway.
Transactivation of DBH by Phox2a is synergistically
enhanced by HAND2; the activity of both HAND2 and Phox2a
is elevated by cAMP. The CRE/AP1 site in the DB1 enhancer
of DBH is critical for the synergistic activation of DBH by
HAND2 (Xu et al., 2003); domain mapping studies suggest
that the HLH domain of HAND2 is critical for interaction with
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data suggest that the cAMP-dependent effects mediated at the
CRE are separate from PKA-dependent phosphorylation effects
on HAND2 that regulate HAND2 dimerization. Low but
significant levels of stimulated DBH-CREM transactivation
occurring in the presence of HAND2 and HAND2DP support
the idea that cAMP and PKA influence different aspects of
DBH promoter regulation; a logical extension of this conclu-
sion is that HAND2 interacts with additional, as yet uniden-
tified sites, in the DBH promoter. It is clear, however, that
PKA-dependent phosphorylation of HAND2 is critical for
regulation of DBH activity and thus synthesis of norepineph-
rine. Our current studies show that PKA-dependent phosphor-
ylation of HAND2 regulates a critical component of HAND2
interaction in the transcription complex with Phox2a. Previous
studies have shown that the DNA binding avidity of Phox2a is
regulated by interactions with HAND2 (Adachi and Lewis,
2002; Rychlik et al., 2003, in press) as well as by PKA-
dependent dephosphorylation. Our data thus suggest a model
(Fig. 11) wherein the balance between dephosphorylation of
Phox2a and phosphorylation of HAND2 may act as a switch
determining the relative functional activity of DBH. The bridge
between HAND2 and Phox2a in this context may be protein
phosphatase 2A (PP2A). It has been suggested that the protein
phosphatase activity of PP2A is stimulated by PKA-dependent
phosphorylation of the B subunit (Usui et al., 1998). The B
subunit determines the substrate specificity of the phosphatase
and we have previously shown that the ratio of phospho-
HAND2 to dephospho-HAND2 is specifically regulated by the
PP2A-targeting subunit, B56y (Firulli et al., 2003). This
subunit has also been implicated in regulating the dephosphor-
ylation of Phox2a (Adachi and Lewis, 2002).
As a whole, our data suggest that BMP4 stimulates PKA
activity independent of increasing levels of cAMP and that this
PKA affects the ability of HAND2 to act as co-transcriptional
regulator with Phox2a of DBH. Our data suggest multiple
functions of PKA for synthesis of norepinephrine; it appears
that sites in the DBH promoter targeted for regulation by
cAMP or PKA depend upon the source of the upstream
signaling inducing their activity.
The choice of neurotransmitter by developing neurons is
one hallmark of a differentiated phenotype. In the autonomic
neuron lineage, it is only those precursors that express both
HAND2 and Phox2a that will differentiate as noradrenergic
neurons (Howard et al., 2000; Muller and Rohrer, 2002;
Howard, 2005). The generation of these cells involves
intracellular signaling mediated by BMP growth factors.
Non-canonical signaling by PKA targets aspects of neurogen-
esis and cell type-specific gene expression. Our model
synthesizes the work reported here as well as data from many
different laboratories, and fills gaps in our understanding of the
integrated function of BMP, HAND2, Phox2, and cAMP.
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